Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for cerebral palsy
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cerebral palsy or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on cerebral palsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
CerebralpalsyCerebralpalsy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search Cerebralpalsy Last reviewed: February 2019 Last updated: February 2019 Summary An umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Most common cause of childhood disability affecting 2.5 per 1000 (...) , and extremity deformity. Definition Cerebralpalsy (CP) is an umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebralpalsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14. http://www.ncbi.nlm.nih.gov/pubmed/17370477?tool=bestpractice.com Secondary effects of spasticity
Sialanar (glycopyrronium) - for treating severe drooling of saliva in children and adolescents (aged 3 years and above) with conditions affecting the nervous system, such as cerebralpalsy, epilepsy and neurodegenerative diseases 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact 21 July 2016 EMA/555265/2016 Committee (...) Pharmacopoeia or blood pressure bpm beats per minute CE Conformité Européene CEP Certificate of Suitability of the Ph.Eur. CHMP Committee for Medicinal Products for Human Use CHO chinese hamster ovary C max maximum concentration in plasma (or serum) CI confidence interval Cl (total plasma) clearance CMS Concerned Member State CNS central nervous system CoA Certificate of Analysis CP cerebralpalsy CRS Chemical Reference Substance (official standard) CSF cerebrospinal fluid CSR clinical study report %CV
CerebralPalsyCerebralPalsy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 CerebralPalsyCerebralPalsy Aka: CerebralPalsy From (...) PalsyBrain cancer Routine Left lateral position more comfortable for pelvic Educate about injury risks risk s XI. References Majoewsky (2012) EM:Rap 2(9): 4 Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "CerebralPalsy." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: CerebralPalsy (C0007789) Definition (CHV) birth injury of the brain nerve
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebralpalsy. Cerebralpalsy (CP) is the most common cause of physical disabilities in children in high-income countries. Spasticity is the most common motor disturbance in CP. Botulinum toxin type A (BoNT-A) is considered the first-line treatment for focal spasticity in people with CP.To evaluate the effectiveness and safety of BoNT-A compared to other treatments used in the management of lower limb spasticity
Early Diagnosis for Children with CerebralPalsy: Clinical Effectiveness and Guidelines Early Diagnosis for Children with CerebralPalsy: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Early Diagnosis for Children with CerebralPalsy: Clinical Effectiveness and Guidelines Early Diagnosis for Children with CerebralPalsy: Clinical Effectiveness and Guidelines Published on: January 10, 2018 Project Number: RB1181-000 Product Line: Research Type: Other Diagnostics (...) Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of early diagnosis in children with cerebralpalsy? What are the evidence-based guidelines addressing early diagnosis in children with cerebralpalsy? Key Message Five systematic reviews, one with meta-analysis, one randomized controlled trial, and one non-randomized study were identified regarding the clinical effectiveness of early diagnosis in children with cerebralpalsy. Tags diagnostic tests
Neonatal interventions for preventing cerebralpalsy: an overview of Cochrane Systematic Reviews. Cerebralpalsy is an umbrella term that encompasses disorders of movement and posture attributed to non-progressive disturbances occurring in the developing foetal or infant brain. As there are diverse risk factors and aetiologies, no one strategy will prevent cerebralpalsy. Therefore, there is a need to systematically consider all potentially relevant interventions for prevention.PrimaryTo (...) summarise the evidence from Cochrane Systematic Reviews regarding effects of neonatal interventions for preventing cerebralpalsy (reducing cerebralpalsy risk).SecondaryTo summarise the evidence from Cochrane Systematic Reviews regarding effects of neonatal interventions that may increase cerebralpalsy risk.We searched the Cochrane Database of Systematic Reviews (27 November 2016) for reviews of neonatal interventions reporting on cerebralpalsy. Two review authors assessed reviews for inclusion
Pharmacologic treatment of spasticity in children and adolescents with cerebralpalsy Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebralpalsy (an evidence-based review) | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share January 26, 2010 ; 74 (4) Special Article Practice Parameter: Pharmacologic treatment of spasticity (...) in children and adolescents with cerebralpalsy (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society M. R. Delgado , D. Hirtz , M. Aisen , S. Ashwal , D. L. Fehlings , J. McLaughlin , L. A. Morrison , M. W. Shrader , A. Tilton , J. Vargus-Adams First published January 25, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181cbcd2f M. R. Delgado D. Hirtz M. Aisen S. Ashwal D. L. Fehlings J
Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with CerebralPalsy. To assess the efficacy and safety of botulinum toxin A (BoNT-A) injected in both submandibular and parotid versus only in parotid glands as a treatment for drooling in patients with spastic and dyskinetic cerebralpalsy (CP), including an assessment of impact on quality of life (QoL) based on items from the International Classification
asa neuroprotective agent is unknown, it hasa number of biologically plausible actions which may contribute to a protective effect on the preterm neonatal brain. The most common pathological lesion associated with cerebralpalsy in preterm infants is periventri- cular white matter injury. 5 Oligodendrocytes constitutea major glial population in the white matter. N-methyl-D-aspartic acid (NMDA) receptors on oligodendrocytes are thought to be important in the glial injury process. NMDA receptor (...) Magnesium Sulphate to Prevent CerebralPalsy following Preterm Birth Magnesium Sulphate to Prevent CerebralPalsy following Preterm Birth Scientific Impact Paper No. 29 August 2011Magnesium Sulphate to Prevent CerebralPalsy following Preterm Birth 1. Background The prevalence of preterm birth is increasing. 1 While the survival of infants born preterm has improved, 2 the prevalence of cerebralpalsy has risen. 3 The incidence of cerebralpalsy decreases significantly with increasing
Periodontal disease in children and young adults with cerebralpalsy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing
Cerebralpalsy Evidence Maps - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4
Intrathecal baclofen for treating spasticity in children with cerebralpalsy. Cerebralpalsy is a disorder of movement and posture arising from a non-progressive lesion in the developing brain. Spasticity, a disorder of increased muscle tone, is the most common motor difficulty and is associated with activity limitation to varying degrees in mobility and self care.Oral baclofen, a gamma-aminobutyric acid (GABA) agonist, has been used in oral form to treat spasticity for some time, but it has (...) baclofen pumps over six months.The four short-term studies demonstrated that intrathecal baclofen therapy reduces spasticity in children with cerebralpalsy. However, two of these studies utilised inappropriate techniques for statistical analysis of results. The single longer-term study demonstrated minimal reduction in spasticity with the use of intrathecal baclofen therapy.One of the short-term studies and the longer term study showed improvement in comfort and ease of care. The longer term study
Combining constraint-induced movement therapy and action-observation training in children with unilateral cerebralpalsy: a randomized controlled trial. Upper limb (UL) deficits in children with unilateral cerebralpalsy (uCP) have traditionally been targeted with motor execution treatment models, such as modified Constraint-Induced Movement Therapy (mCIMT). However, new approaches based on a neurophysiological model such as Action-Observation Training (AOT) may provide new opportunities (...) human motion. The primary outcome measure will be the Assisting Hand Assessment. Secondary outcomes comprise clinical assessments across body function, activity and participation level of the International Classification of Function, Disability and Health. Furthermore, to quantitatively evaluate UL movement patterns, a three-dimensional motion analysis will be conducted. UL function will be assessed at baseline, immediately before and after intervention and at 6 months follow up. Brain imaging
Effectiveness of aquatic interventions for children with cerebralpalsy: systematic review of the current literature Effectiveness of aquatic interventions for children with cerebralpalsy: systematic review of the current literature Effectiveness of aquatic interventions for children with cerebralpalsy: systematic review of the current literature Blohm D CRD summary The review concluded that the evidence suggested aquatic interventions were beneficial for children and adolescents (...) with cerebralpalsy. The author's conclusions reflected the evidence presented, but the potential for missed studies, lack of reporting of review methods, and limitations in the evidence mean the reliability of the conclusions is uncertain. Authors' objectives To evaluate the effectiveness of aquatic interventions for children or adolescents with cerebralpalsy. Searching PubMed, CINAHL, PEDro, SPORTDiscus and The Cochrane Library were searched for articles in English or German published in peer-reviewed
Impact of Hippotherapy on Gross Motor Function and Quality of Life in Children with Bilateral CerebralPalsy: A Randomized Open-Label Crossover Study. This study investigated the effect of hippotherapy on gross motor function (Gross Motor Function Measure [GMFM]-66, GMFM dimension E and D) and quality of life (Child Health Questionnaire [CHQ 28], KIDSCREEN-27 parental versions) in children with bilateral spastic cerebralpalsy. Seventy-three children (age: 9.1 ± 3.3 years; male = 44; GMFCS (...) psychosocial quality of life scores than children who completed the whole study (CHQ-28 "psychosocial dimension"; KIDSCREEN-27 "mood and emotional dimension"). Our data are in line with previous reports and suggest that hippotherapy shows distinct therapeutic strengths with regard to promoting upright stand and gait in children with cerebralpalsy. Children with higher psychosocial burden of disease may need special support to get access to and benefit from intensified physiotherapy programs.Georg Thieme